Skip to content
Riskpilot
← Back to search
Sign in
Get full access
75PHARMA AB
AB
Active
Org 5591937999
Malmskillnadsgatan 44 A, 111 57
Stockholm
Retail sale of pharmaceutical products
· NACE 4773
Est. 2019
0 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
75PHARMA AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2021
0M
2022
-1M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−466
−153
−123
−966
−448
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−466
−153
−123
−966
−448
Net financials
—
—
—
−1
−1
Profit before tax
−466
−153
−123
−966
−449
Tax
−0
−0
−0
−0
−0
Net profit
−466
−153
−123
−966
−449
Balance sheet
SEK thousands
Item
2021
2021
2022
2023
2024
Total assets
746
607
535
835
1 259
Equity
−216
538
414
249
250
Long-term debt
0
0
0
0
0
Short-term debt
962
69
121
585
1 009
Total debt
962
69
121
585
1 009
Financial ratios
5-year trend
EBITDA margin
-44800000.0%
This company
15.8%
Market median
-283544404% vs market
2021
2024
Equity ratio
19.9%
This company
38.2%
Market median
-48% vs market
2021
2024
Return on equity
-179.6%
This company
18.4%
Market median
-1076% vs market
2021
2024
Net profit margin
-44900000.0%
This company
8.1%
Market median
-554321088% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
4.04×
This company
0.62×
Market median
-552% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2021-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on 75PHARMA AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network